WallStreetZenWallStreetZen

NASDAQ: CELC
Celcuity Inc Stock Forecast, Predictions & Price Target

Analyst price target for CELC

Based on 4 analysts offering 12 month price targets for Celcuity Inc.
Min Forecast
$23.00+45.57%
Avg Forecast
$29.25+85.13%
Max Forecast
$40.00+153.16%

Should I buy or sell CELC stock?

Based on 4 analysts offering ratings for Celcuity Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CELC stock forecasts and price targets.

CELC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-31
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-16

1 of 1

Forecast return on equity

Is CELC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.85%

Forecast return on assets

Is CELC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CELC revenue forecast

What is CELC's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$7.0M
Avg 2 year Forecast
$50.3M
Avg 3 year Forecast
$240.1M

CELC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELC$15.80$29.25+85.13%Strong Buy
KALV$11.67$27.50+135.65%Buy
CABA$10.19$36.20+255.25%Strong Buy
IGMS$8.33$15.25+83.07%Buy
APLT$4.28$11.00+157.01%Strong Buy

Celcuity Stock Forecast FAQ

Is Celcuity Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CELC) stock is to Strong Buy CELC stock.

Out of 4 analysts, 1 (25%) are recommending CELC as a Strong Buy, 3 (75%) are recommending CELC as a Buy, 0 (0%) are recommending CELC as a Hold, 0 (0%) are recommending CELC as a Sell, and 0 (0%) are recommending CELC as a Strong Sell.

If you're new to stock investing, here's how to buy Celcuity stock.

What is CELC's revenue growth forecast for 2025-2027?

(NASDAQ: CELC) Celcuity's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.

Celcuity's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast CELC's revenue for 2025 to be $218,610,595, with the lowest CELC revenue forecast at $218,610,595, and the highest CELC revenue forecast at $218,610,595. On average, 3 Wall Street analysts forecast CELC's revenue for 2026 to be $1,571,372,957, with the lowest CELC revenue forecast at $760,452,570, and the highest CELC revenue forecast at $2,373,486,460.

In 2027, CELC is forecast to generate $7,499,592,612 in revenue, with the lowest revenue forecast at $6,323,155,310 and the highest revenue forecast at $9,086,393,231.

What is CELC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CELC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CELC's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CELC price target, the average CELC price target is $29.25, with the highest CELC stock price forecast at $40.00 and the lowest CELC stock price forecast at $23.00.

On average, Wall Street analysts predict that Celcuity's share price could reach $29.25 by May 31, 2025. The average Celcuity stock price prediction forecasts a potential upside of 85.13% from the current CELC share price of $15.80.

What is CELC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CELC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.